Clinical Trials Browser

Phase 3 × Not yet recruiting × ribociclib × Clear all

NCT07400523 2026-02-10

Ribociclib in Hormone Receptor-positive, HER2-negative Early Breast Cancer With Residual Disease After Neoadjuvant Chemotherapy

Phase 3 Not yet recruiting

Breast Neoplasms